Skip to content
Recall Observatory FDA recall evidence

Drug product

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

D-0921-2017

June 01, 2017

Class II

Product summary

Firm
Lucid Pharma LLC
Event
Event 77427
Status
Terminated
Classification
Class II
Quantity
a) 44168 bottles; b) 24960 bottles
Official record key
drug-enforcement:D-0921-2017

Official wording

Reason: Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

Code information: Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.